A MediCom Oncology Site
This website uses cookies. By using our site you agree to our privacy policy
Username:
Password:
Lost username/password
Create an account
  • Home
  • About Us
    • Contact Us
    • Accreditation
    • MediCom Worldwide, Inc.
  • Reference
    • What is Multiple Myeloma?
    • FAQ Library
    • Clinical Pearls Podcasts
  • CE Education
    • Developments in NDMM
    • Examining the Evidence in Frontline Therapy
    • Annual Meeting Highlights
    • Accredited E-Newsletter Series
    • Practice Essentials
  • Resources
    • Web Links
    • Newsletters
  • March is Myeloma Awareness Month
  • March is Bleeding Disorders Awareness Month
  • Advances and Evolving Standards of Care in Transplant-eligible NDMM
  • Advances and Evolving Standards of Care in Transplant-ineligible NDMM
  • Managing Myeloma: Examining the Evidence in Frontline Therapy
  • Highlights in Multiple Myeloma from the Annual ASCO and EHA 2022 Meetings
  • Developments in Newly Diagnosed Multiple Myeloma: Considerations for Improved Patient Outcomes
  • What is Multiple Myeloma
  • Visit Our FAQ Library Now!
  • Practice Essentials in Multiple Myeloma
Highlights in Multiple Myeloma from the Annual ASCO and EHA 2022 Meetings

Joshua Richter, MD

Managing Myeloma: Examining the Evidence in Frontline Therapy

Amrita Krishnan, MD, FACP and Saad Z. Usmani, MD, MBA, FACP

Advances and Evolving Standards of Care in Transplant-ineligible NDMM

Saad Z. Usmani, MD, FACP




Advances and Evolving Standards of Care in Transplant-eligible NDMM

Amrita Krishnan, MD, FACP
FAQ

Developments in Newly Diagnosed Multiple Myeloma: Considerations for Improved Patient Outcomes

Sagar Lonial, MD, FACP and Saad Z. Usmani, MD, FACP

What do you see for the future of myeloma treatment?

Joshua Richter, MD

Mini Medical Crossword

Trending Now

Managing Myeloma: Examining the Evidence in Frontline Therapy

Amrita Krishnan, MD, FACP and Saad Z. Usmani, MD, MBA, FACP

Advances and Evolving Standards of Care in Transplant-ineligible NDMM

Saad Z. Usmani, MD, FACP

Highlights in Multiple Myeloma from the Annual ASCO and EHA 2022 Meetings

Joshua Richter, MD

Developments in Newly Diagnosed Multiple Myeloma: Considerations for Improved Patient Outcomes

Sagar Lonial, MD, FACP and Saad Z. Usmani, MD, FACP

What are the new and notable findings from EHA and ASCO that are relevant to transplant eligible newly diagnosed multiple myeloma?

Joshua Richter, MD

What are the challenges and unmet needs associated with managing multiple myeloma today?

Joshua Richter, MD

MO Signup MailChimp
MedicalEd
Subscribe Today to join our
MedicalEd Digest
mailing list!

Your email address will not be shared with any third party, nor sold

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMDS.com | ManagingMPN.com | ManagingLymphoma.com | PracticalOncologist.com | MediComWorldwide.com

©2023 MediCom Worldwide, Inc. All rights reserved
  • Privacy, Terms, and Conditions
  • Contact Us